25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

TG Therapeutics Inc
Buy, Hold or Sell?

Let's analyze TG Therapeutics Inc together

I guess you are interested in TG Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of TG Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about TG Therapeutics Inc

I send you an email if I find something interesting about TG Therapeutics Inc.

1. Quick Overview

1.1. Quick analysis of TG Therapeutics Inc (30 sec.)










1.2. What can you expect buying and holding a share of TG Therapeutics Inc? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€1.02
Expected worth in 1 year
€3.57
How sure are you?
66.7%

+ What do you gain per year?

Total Gains per Share
€2.55
Return On Investment
8.3%

For what price can you sell your share?

Current Price per Share
€30.62
Expected price per share
€26.52 - €34.44
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of TG Therapeutics Inc (5 min.)




Live pricePrice per Share (EOD)
€30.62
Intrinsic Value Per Share
€0.18 - €9.51
Total Value Per Share
€1.20 - €10.53

2.2. Growth of TG Therapeutics Inc (5 min.)




Is TG Therapeutics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$160.5m$58.5m$101.9m63.5%

How much money is TG Therapeutics Inc making?

Current yearPrevious yearGrowGrow %
Making money$12.6m-$198.3m$211m1,665.1%
Net Profit Margin5.4%-7,121.5%--

How much money comes from the company's main activities?

2.3. Financial Health of TG Therapeutics Inc (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of TG Therapeutics Inc?

Welcome investor! TG Therapeutics Inc's management wants to use your money to grow the business. In return you get a share of TG Therapeutics Inc.

First you should know what it really means to hold a share of TG Therapeutics Inc. And how you can make/lose money.

Speculation

The Price per Share of TG Therapeutics Inc is €30.62. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of TG Therapeutics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in TG Therapeutics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €1.02. Based on the TTM, the Book Value Change Per Share is €0.64 per quarter. Based on the YOY, the Book Value Change Per Share is €-1.21 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of TG Therapeutics Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.080.3%0.080.3%-1.35-4.4%-1.51-4.9%-1.61-5.2%
Usd Book Value Change Per Share0.662.2%0.662.2%-1.26-4.1%0.150.5%0.180.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.662.2%0.662.2%-1.26-4.1%0.150.5%0.180.6%
Usd Price Per Share16.32-16.32-10.55-19.46-16.78-
Price to Earnings Ratio195.03-195.03--7.79-30.62-25.25-
Price-to-Total Gains Ratio24.74-24.74--8.41-34.03-30.30-
Price to Book Ratio15.40-15.40-26.36-18.42-17.30-
Price-to-Total Gains Ratio24.74-24.74--8.41-34.03-30.30-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share31.7263245
Number of shares31
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.660.15
Usd Total Gains Per Share0.660.15
Gains per Quarter (31 shares)20.454.80
Gains per Year (31 shares)81.8119.18
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1082720199
2016415403828
3024523605847
4032731807766
5040940009685
604914820115104
705735640134123
806546460153142
907367280173161
1008188100192180

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%1.02.00.033.3%1.04.00.020.0%1.05.00.016.7%1.05.00.016.7%
Book Value Change Per Share1.00.00.0100.0%1.02.00.033.3%3.02.00.060.0%4.02.00.066.7%4.02.00.066.7%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.06.00.0%0.00.06.00.0%
Total Gains per Share1.00.00.0100.0%1.02.00.033.3%3.02.00.060.0%4.02.00.066.7%4.02.00.066.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of TG Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.6370.6370%-1.211+290%0.149+327%0.170+273%
Book Value Per Share--1.0231.0230%0.386+165%1.382-26%1.198-15%
Current Ratio--5.9195.9190%3.163+87%4.579+29%4.155+42%
Debt To Asset Ratio--0.5130.5130%0.697-26%0.504+2%0.539-5%
Debt To Equity Ratio--1.0531.0530%2.304-54%0.833+27%1.107-5%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--2221765526.7502221765526.7500%1360235495.616+63%2504708947.220-11%2122825316.614+5%
Eps--0.0810.0810%-1.307+1719%-1.460+1909%-1.550+2019%
Ev To Ebitda Ratio--infinfnan%-7.492nan%infnan%infnan%
Ev To Sales Ratio--9.8539.8530%506.129-98%9261.888-100%7960.726-100%
Free Cash Flow Per Share---0.200-0.2000%-1.161+480%-1.266+532%-1.302+550%
Free Cash Flow To Equity Per Share--0.2630.2630%-1.164+542%0.451-42%0.347-24%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--9.511--------
Intrinsic Value_10Y_min--0.178--------
Intrinsic Value_1Y_max---0.673--------
Intrinsic Value_1Y_min---0.952--------
Intrinsic Value_3Y_max---0.784--------
Intrinsic Value_3Y_min---2.037--------
Intrinsic Value_5Y_max--0.600--------
Intrinsic Value_5Y_min---2.212--------
Market Cap--2384932551.7502384932551.7500%1490496020.616+60%2635415688.220-10%2241330050.780+6%
Net Profit Margin--0.0540.0540%-71.215+131416%-662.646+1221968%-742.426+1369077%
Operating Margin----0%-0%-0%-0%
Operating Ratio--0.9720.9720%70.337-99%648.230-100%731.586-100%
Pb Ratio29.931+49%15.39815.3980%26.363-42%18.419-16%17.296-11%
Pe Ratio379.103+49%195.031195.0310%-7.788+104%30.622+537%25.249+672%
Price Per Share30.615+49%15.75015.7500%10.182+55%18.781-16%16.189-3%
Price To Free Cash Flow Ratio-152.930-94%-78.675-78.6750%-8.767-89%-26.091-67%-22.105-72%
Price To Total Gains Ratio48.089+49%24.73924.7390%-8.405+134%34.028-27%30.303-18%
Quick Ratio--3.2703.2700%1.116+193%1.115+193%1.044+213%
Return On Assets--0.0380.0380%-1.025+2765%-0.722+1978%-0.948+2564%
Return On Equity--0.0790.0790%-3.385+4388%-1.062+1446%-2.088+2745%
Total Gains Per Share--0.6370.6370%-1.211+290%0.149+327%0.170+273%
Usd Book Value--160506734.809160506734.8090%58588728.317+174%202847383.821-21%173045604.695-7%
Usd Book Value Change Per Share--0.6600.6600%-1.255+290%0.155+327%0.177+273%
Usd Book Value Per Share--1.0601.0600%0.400+165%1.433-26%1.242-15%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--2302415615.3712302415615.3710%1409612044.107+63%2595629882.005-11%2199883875.607+5%
Usd Eps--0.0840.0840%-1.355+1719%-1.514+1909%-1.606+2019%
Usd Free Cash Flow---31413926.684-31413926.6840%-176189197.428+461%-177655640.687+466%-169549501.563+440%
Usd Free Cash Flow Per Share---0.207-0.2070%-1.204+480%-1.312+532%-1.349+550%
Usd Free Cash Flow To Equity Per Share--0.2730.2730%-1.206+542%0.468-42%0.359-24%
Usd Market Cap--2471505603.3792471505603.3790%1544601026.164+60%2731081277.703-10%2322690331.624+6%
Usd Price Per Share31.726+49%16.32216.3220%10.552+55%19.463-16%16.777-3%
Usd Profit--12672373.82412672373.8240%-198340850.883+1665%-203735610.023+1708%-198694194.639+1668%
Usd Revenue--233668893.029233668893.0290%2785082.158+8290%48689436.296+380%40599864.327+476%
Usd Total Gains Per Share--0.6600.6600%-1.255+290%0.155+327%0.177+273%
 EOD+3 -3MRQTTM+0 -0YOY+32 -35Y+20 -1510Y+26 -9

3.3 Fundamental Score

Let's check the fundamental score of TG Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15379.103
Price to Book Ratio (EOD)Between0-129.931
Net Profit Margin (MRQ)Greater than00.054
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than13.270
Current Ratio (MRQ)Greater than15.919
Debt to Asset Ratio (MRQ)Less than10.513
Debt to Equity Ratio (MRQ)Less than11.053
Return on Equity (MRQ)Greater than0.150.079
Return on Assets (MRQ)Greater than0.050.038
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of TG Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.477
Ma 20Greater thanMa 5028.631
Ma 50Greater thanMa 10030.036
Ma 100Greater thanMa 20026.288
OpenGreater thanClose31.925
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About TG Therapeutics Inc

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit TG Therapeutics Inc earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare TG Therapeutics Inc to the  industry mean.
  • A Net Profit Margin of 5.4% means that €0.05 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of TG Therapeutics Inc:

  • The MRQ is 5.4%. The company is making a profit. +1
  • The TTM is 5.4%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ5.4%TTM5.4%0.0%
TTM5.4%YOY-7,121.5%+7,127.0%
TTM5.4%5Y-66,264.6%+66,270.0%
5Y-66,264.6%10Y-74,242.6%+7,978.1%
4.3.1.2. Return on Assets

Shows how efficient TG Therapeutics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare TG Therapeutics Inc to the  industry mean.
  • 3.8% Return on Assets means that TG Therapeutics Inc generated €0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of TG Therapeutics Inc:

  • The MRQ is 3.8%. Using its assets, the company is less efficient in making profit.
  • The TTM is 3.8%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ3.8%TTM3.8%0.0%
TTM3.8%YOY-102.5%+106.3%
TTM3.8%5Y-72.2%+76.1%
5Y-72.2%10Y-94.8%+22.5%
4.3.1.3. Return on Equity

Shows how efficient TG Therapeutics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare TG Therapeutics Inc to the  industry mean.
  • 7.9% Return on Equity means TG Therapeutics Inc generated €0.08 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of TG Therapeutics Inc:

  • The MRQ is 7.9%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 7.9%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ7.9%TTM7.9%0.0%
TTM7.9%YOY-338.5%+346.4%
TTM7.9%5Y-106.2%+114.1%
5Y-106.2%10Y-208.8%+102.6%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of TG Therapeutics Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient TG Therapeutics Inc is operating .

  • Measures how much profit TG Therapeutics Inc makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare TG Therapeutics Inc to the  industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of TG Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
4.3.2.2. Operating Ratio

Measures how efficient TG Therapeutics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 0.97 means that the operating costs are €0.97 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of TG Therapeutics Inc:

  • The MRQ is 0.972. The company is less efficient in keeping operating costs low.
  • The TTM is 0.972. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.972TTM0.9720.000
TTM0.972YOY70.337-69.365
TTM0.9725Y648.230-647.257
5Y648.23010Y731.586-83.356
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of TG Therapeutics Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if TG Therapeutics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 5.92 means the company has €5.92 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of TG Therapeutics Inc:

  • The MRQ is 5.919. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.919. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.919TTM5.9190.000
TTM5.919YOY3.163+2.756
TTM5.9195Y4.579+1.339
5Y4.57910Y4.155+0.424
4.4.3.2. Quick Ratio

Measures if TG Therapeutics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare TG Therapeutics Inc to the  industry mean.
  • A Quick Ratio of 3.27 means the company can pay off €3.27 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of TG Therapeutics Inc:

  • The MRQ is 3.270. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.270. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.270TTM3.2700.000
TTM3.270YOY1.116+2.154
TTM3.2705Y1.115+2.155
5Y1.11510Y1.044+0.071
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of TG Therapeutics Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of TG Therapeutics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare TG Therapeutics Inc to industry mean.
  • A Debt to Asset Ratio of 0.51 means that TG Therapeutics Inc assets are financed with 51.3% credit (debt) and the remaining percentage (100% - 51.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of TG Therapeutics Inc:

  • The MRQ is 0.513. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.513. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.513TTM0.5130.000
TTM0.513YOY0.697-0.184
TTM0.5135Y0.504+0.009
5Y0.50410Y0.539-0.035
4.5.4.2. Debt to Equity Ratio

Measures if TG Therapeutics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare TG Therapeutics Inc to the  industry mean.
  • A Debt to Equity ratio of 105.3% means that company has €1.05 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of TG Therapeutics Inc:

  • The MRQ is 1.053. The company is able to pay all its debts with equity. +1
  • The TTM is 1.053. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.053TTM1.0530.000
TTM1.053YOY2.304-1.251
TTM1.0535Y0.833+0.221
5Y0.83310Y1.107-0.274
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings TG Therapeutics Inc generates.

  • Above 15 is considered overpriced but always compare TG Therapeutics Inc to the  industry mean.
  • A PE ratio of 195.03 means the investor is paying €195.03 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of TG Therapeutics Inc:

  • The EOD is 379.103. Based on the earnings, the company is expensive. -2
  • The MRQ is 195.031. Based on the earnings, the company is expensive. -2
  • The TTM is 195.031. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD379.103MRQ195.031+184.072
MRQ195.031TTM195.0310.000
TTM195.031YOY-7.788+202.819
TTM195.0315Y30.622+164.409
5Y30.62210Y25.249+5.373
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of TG Therapeutics Inc:

  • The EOD is -152.930. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -78.675. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -78.675. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-152.930MRQ-78.675-74.255
MRQ-78.675TTM-78.6750.000
TTM-78.675YOY-8.767-69.909
TTM-78.6755Y-26.091-52.585
5Y-26.09110Y-22.105-3.986
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of TG Therapeutics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of 15.40 means the investor is paying €15.40 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of TG Therapeutics Inc:

  • The EOD is 29.931. Based on the equity, the company is expensive. -2
  • The MRQ is 15.398. Based on the equity, the company is expensive. -2
  • The TTM is 15.398. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD29.931MRQ15.398+14.533
MRQ15.398TTM15.3980.000
TTM15.398YOY26.363-10.965
TTM15.3985Y18.419-3.021
5Y18.41910Y17.296+1.123
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Income before Tax  -198,310-71,292-269,603-66,315-335,917144,524-191,393203,99812,605
Net Income  -198,310-71,292-269,603-66,315-335,917144,524-191,393203,62212,228
Operating Income  -192,916-71,102-264,018-68,685-332,703146,613-186,090206,00019,911
Net Income from Continuing Operations  -198,310-71,292-269,603-66,315-335,917144,524-191,393203,62212,228



6.2. Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets329,587
Total Liabilities169,085
Total Stockholder Equity160,502
 As reported
Total Liabilities 169,085
Total Stockholder Equity+ 160,502
Total Assets = 329,587

Assets

Total Assets329,587
Total Current Assets317,943
Long-term Assets11,644
Total Current Assets
Cash And Cash Equivalents 92,933
Short-term Investments 124,575
Net Receivables 51,093
Inventory 39,823
Other Current Assets 5,336
Total Current Assets  (as reported)317,943
Total Current Assets  (calculated)313,760
+/- 4,183
Long-term Assets
Property Plant Equipment 9,560
Goodwill 799
Long-term Assets Other 1,285
Long-term Assets  (as reported)11,644
Long-term Assets  (calculated)11,644
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities53,720
Long-term Liabilities115,365
Total Stockholder Equity160,502
Total Current Liabilities
Other Current Liabilities 1,631
Total Current Liabilities  (as reported)53,720
Total Current Liabilities  (calculated)1,631
+/- 52,089
Long-term Liabilities
Long term Debt 100,118
Capital Lease Obligations Min Short Term Debt10,677
Long-term Liabilities  (as reported)115,365
Long-term Liabilities  (calculated)110,795
+/- 4,570
Total Stockholder Equity
Total Stockholder Equity (as reported)160,502
Total Stockholder Equity (calculated)0
+/- 160,502
Other
Capital Stock151
Common Stock Shares Outstanding 151,424
Net Debt 7,185
Net Invested Capital 260,620
Net Working Capital 264,223
Property Plant and Equipment Gross 9,560



6.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
> Total Assets 
83,616
163,014
625,642
379,629
193,572
329,587
329,587193,572379,629625,642163,01483,616
   > Total Current Assets 
79,031
149,151
611,740
330,965
168,274
317,943
317,943168,274330,965611,740149,15179,031
       Cash And Cash Equivalents 
41,958
112,637
553,439
298,887
102,304
92,933
92,933102,304298,887553,439112,63741,958
       Short-term Investments 
26,848
27,798
51,987
15,876
59,374
124,575
124,57559,37415,87651,98727,79826,848
       Net Receivables 
0
0
0
1,389
0
51,093
51,09301,389000
       Other Current Assets 
439
611
1,083
2,884
2,359
5,336
5,3362,3592,8841,083611439
   > Long-term Assets 
4,585
13,863
13,902
48,664
25,298
11,644
11,64425,29848,66413,90213,8634,585
       Property Plant Equipment 
0
11,813
11,844
11,068
10,822
9,560
9,56010,82211,06811,84411,8130
       Goodwill 
799
799
799
799
799
799
799799799799799799
       Long Term Investments 
0
0
0
35,533
12,404
0
012,40435,533000
       Long-term Assets Other 
1,241
1,251
1,259
1,264
1,273
1,285
1,2851,2731,2641,2591,2511,241
> Total Liabilities 
59,580
124,399
106,292
142,476
134,985
169,085
169,085134,985142,476106,292124,39959,580
   > Total Current Liabilities 
38,854
84,449
87,554
65,384
53,201
53,720
53,72053,20165,38487,55484,44938,854
       Short Long Term Debt 
67
0
22,179
975
0
0
0097522,179067
       Other Current Liabilities 
0
48,994
18,236
1,512
1,169
1,631
1,6311,1691,51218,23648,9940
   > Long-term Liabilities 
20,726
39,950
18,738
77,092
81,784
115,365
115,36581,78477,09218,73839,95020,726
       Capital Lease Obligations Min Short Term Debt
0
11,834
12,081
11,284
11,925
10,677
10,67711,92511,28412,08111,8340
       Long-term Liabilities Other 
18,350
0
0
0
0
0
0000018,350
> Total Stockholder Equity
24,036
-701,216
519,350
237,153
58,587
160,502
160,50258,587237,153519,350-701,21624,036
   Common Stock000000
   Retained Earnings Total Equity000000
   Accumulated Other Comprehensive Income 000000
   Capital Surplus 000000
   Treasury Stock000000
   Other Stockholders Equity 000000



6.4. Balance Sheets

Currency in USD. All numbers in thousands.




6.5. Cash Flows

Currency in USD. All numbers in thousands.




6.6. Income Statements

Currency in USD. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue233,662
Cost of Revenue-14,131
Gross Profit219,531219,531
 
Operating Income (+$)
Gross Profit219,531
Operating Expense-213,029
Operating Income20,6336,502
 
Operating Expense (+$)
Research Development76,192
Selling General Administrative122,706
Selling And Marketing Expenses0
Operating Expense213,029198,898
 
Net Interest Income (+$)
Interest Income0
Interest Expense-12,615
Other Finance Cost-0
Net Interest Income-12,615
 
Pretax Income (+$)
Operating Income20,633
Net Interest Income-12,615
Other Non-Operating Income Expenses0
Income Before Tax (EBT)13,06215,589
EBIT - interestExpense = -12,615
12,672
25,287
Interest Expense12,615
Earnings Before Interest and Taxes (EBIT)025,677
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax13,062
Tax Provision-390
Net Income From Continuing Ops12,67212,672
Net Income12,672
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net5,04412,615
 

Technical Analysis of TG Therapeutics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of TG Therapeutics Inc. The general trend of TG Therapeutics Inc is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine TG Therapeutics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of TG Therapeutics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 32.46 < 33.34 < 34.44.

The bearish price targets are: 29.08 > 27.34 > 26.52.

Tweet this
TG Therapeutics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of TG Therapeutics Inc. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

TG Therapeutics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of TG Therapeutics Inc. The current macd is 0.47904941.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the TG Therapeutics Inc price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for TG Therapeutics Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the TG Therapeutics Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
TG Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) ChartTG Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of TG Therapeutics Inc. The current adx is 16.46.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy TG Therapeutics Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
TG Therapeutics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of TG Therapeutics Inc. The current sar is 27.54.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
TG Therapeutics Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of TG Therapeutics Inc. The current rsi is 55.48. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
TG Therapeutics Inc Daily Relative Strength Index (RSI) ChartTG Therapeutics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of TG Therapeutics Inc. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the TG Therapeutics Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
TG Therapeutics Inc Daily Stochastic Oscillator ChartTG Therapeutics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of TG Therapeutics Inc. The current cci is 121.59.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
TG Therapeutics Inc Daily Commodity Channel Index (CCI) ChartTG Therapeutics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of TG Therapeutics Inc. The current cmo is 14.43.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
TG Therapeutics Inc Daily Chande Momentum Oscillator (CMO) ChartTG Therapeutics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of TG Therapeutics Inc. The current willr is -35.30552861.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that TG Therapeutics Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
TG Therapeutics Inc Daily Williams %R ChartTG Therapeutics Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of TG Therapeutics Inc.

TG Therapeutics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of TG Therapeutics Inc. The current atr is 0.96290782.

TG Therapeutics Inc Daily Average True Range (ATR) ChartTG Therapeutics Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of TG Therapeutics Inc. The current obv is -27,326.

TG Therapeutics Inc Daily On-Balance Volume (OBV) ChartTG Therapeutics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of TG Therapeutics Inc. The current mfi is 100.00.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
TG Therapeutics Inc Daily Money Flow Index (MFI) ChartTG Therapeutics Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for TG Therapeutics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-09-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-20MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-07STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-08STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-09WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-18STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-21STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-23STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-05STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-06CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-07ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-11STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-13STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-25RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-11-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-29MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-12-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-17CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-12-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-01-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-06BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-13STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-14STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-01-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-01-24STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-01-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-31ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

TG Therapeutics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of TG Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.477
Ma 20Greater thanMa 5028.631
Ma 50Greater thanMa 10030.036
Ma 100Greater thanMa 20026.288
OpenGreater thanClose31.925
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of TG Therapeutics Inc with someone you think should read this too:
  • Are you bullish or bearish on TG Therapeutics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about TG Therapeutics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about TG Therapeutics Inc

I send you an email if I find something interesting about TG Therapeutics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about TG Therapeutics Inc.

Receive notifications about TG Therapeutics Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.